Michael H. Knight

Jones Day (Washington DC)
Lawyer (Partner)

Mike Knight is partner at Jones Day (Washington). He advises clients on all aspects of competition law, including mergers, joint ventures, competitor collaborations, distribution issues, price discrimination, monopolization, and intellectual property restraints. He has experience in government and the private sector and routinely represents clients before federal and state antitrust agencies and federal courts. From 2003 to 2007, Mike served as an assistant director of the Federal Trade Commission’s Bureau of Competition, where he headed the Bureau’s Mergers II Division, overseeing hundreds of investigations, including the Blockbuster/Hollywood, Sony/BMG, and Brocade/McData transactions. He was a trial attorney at the U.S. Department of Justice Antitrust Division from 1997 to 2000. In private practice before joining Jones Day, Mike represented technology firms Adobe, NVIDIA, and Synopsys, among other clients. Mike currently serves as a vice chair of the American Bar Association Section of Antitrust Law’s Joint Conduct Committee. He writes and speaks frequently on antitrust enforcement topics.

Distinctions

Linked authors

Jones Day (Washington DC)
Jones Day (Washington DC)
Jones Day (Washington DC)
Skadden, Arps, Slate, Meagher & Flom (Washington DC)
Jones Day (Washington DC)
Jones Day (Chicago)
Jones Day (Washington DC)
Jones Day (Washington DC)

Articles

4022 Bulletin

Kathryn M. Fenton, Michael H. Knight, J. Bruce McDonald, Ryan C. Thomas, Thomas D. York The U.S. District Court of Columbia rejects the Government’s challenge to a vertical merger between an entertainment company and a distribution company (AT&T / Time Warner)

44

Court Rejects DOJ Antitrust Challenge to AT&T/Time Warner* After eighteen months of investigation and litigation, a federal district court has rejected the Justice Department’s challenge to AT&T’s $108 billion acquisition of Time Warner Inc. Although the government could appeal, the (...)

J. Bruce McDonald, Kathryn M. Fenton, Michael H. Knight, Nathaniel J. Harris , Ryan C. Thomas, Thomas D. York The US FTC publishes a blog post reminding merging parties to avoid creating antitrust liability through the exchange of competitively sensitive information during merger negotiations

313

In Short The Situation: The Federal Trade Commission ("FTC") recently published a blog post reminding merging parties to avoid creating antitrust liability through the exchange of competitively sensitive information during merger negotiations and due diligence. The Risk: Information-sharing (...)

David P. Wales, Kathryn M. Fenton, Michael H. Knight, Paula W. Render, Thomas D. York The Federal Trade Commission revises the Merger rules which implements automatic atay of Administrative litigation when Agency loses preliminary injunction in Court

68

One important procedural difference between merger challenges by the U.S. Department of Justice and the Federal Trade Commission is that FTC may challenge a non-consummated merger through both a district court preliminary injunction and administrative litigation (Part 3 adjudication). Recent (...)

Michael H. Knight, Michael Sennett, Philip A. Proger The U.S. FTC releases a summary of its new report on pharma patent litigation finding an increase in "reverse payment" settlements based on expanded definition of "payments"

614

With the Supreme Court set to address the validity of "reverse payment" settlements of pharmaceutical patent litigation, the FTC released a summary of its new report, announcing that in 2012 drug companies entered "a record number" of such settlements. However, the underlying data and analysis (...)

David P. Wales, Geoffrey D. Oliver, Michael H. Knight The U.S. FTC sues to undo completed acquisition in the healthcare industry approved by bankruptcy court (LabCorp / Westcliff)

502

The Federal Trade Commission has filed an administrative lawsuit seeking to undo Laboratory Corporation of America’s (« LabCorp ») acquisition of Westcliff Medical Laboratories, Inc. (« Westcliff »). According to the agency’s December 1 complaint, the merger will substantially lessen competition (...)

David P. Wales, Geoffrey D. Oliver, Michael H. Knight The US FTC sues to undo completed acquisition in the healthcare industry approved by bankruptcy court (LabCorp, Westcliff)

83

The Federal Trade Commission has filed an administrative lawsuit seeking to undo Laboratory Corporation of America’s (« LabCorp ») acquisition of Westcliff Medical Laboratories, Inc. (« Westcliff »). According to the agency’s December 1 complaint, the merger will substantially lessen competition (...)

Geoffrey D. Oliver, Michael H. Knight, Toby G. Singer The US District Court for the District of Minnesota dismisses FTC complaint seeking divestiture and disgorgement remedy in consummated acquisition in the healthcare industry (Lundbeck)

1185

In a decision that was filed under seal in late August but released publicly just last week, the U.S. District Court for the District of Minnesota dismissed with prejudice the complaint filed by the Federal Trade Commission (FTC) and the State of Minnesota challenging the already-consummated (...)

Send a message